Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.74 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.70 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | MGAM | O43451 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | XDH | P47989 | 1/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.57 |
| ▸ | SLC5A2 | P31639 | 6/20 | 0.57 |
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30384586 | 1.00 | PTPN1 (0.74) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| SCHEMBL25279943 | 0.90 | MGAM (0.63) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| SCHEMBL1659323 | 0.90 | CYP19A1 (0.64) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| SCHEMBL25234217 | 0.90 | MGAM (0.63) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| SCHEMBL31233320 | 0.90 | CYP19A1 (0.64) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| Licoagrochalcone A SCHEMBL30384736 | 0.85 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| Licoagrochalcone A SCHEMBL632907 | 0.85 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| Licoagrochalcone A SCHEMBL632908 | 0.85 | PTPN1 (1.00) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| Drupanin SCHEMBL3680290 | 0.82 | AKR1C3 (1.00) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 | |
| Drupanin SCHEMBL5144749 | 0.82 | AKR1C3 (1.00) | PTPN1AKR1B10AKR1B1AKR1C3PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190046469-A1 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE | KUHRTS ERIC HAUSER (US) | 2019-02-14 | — | — | US | claimed |
| US-20150209307-A1 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE | KUHRTS ERIC HAUSER (US) | 2015-07-30 | — | — | US | claimed |
| WO-2014025989-A1 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE | KUHRTS ERIC HAUSER (US) | 2014-02-13 | — | — | WO | claimed |
| US-20140045904-A1 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE EFFECT | KUHRTS ERIC HAUSER (US) | 2014-02-13 | — | — | US | claimed |
| WO-2012051107-A2 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE-EFFECT | KUHRTS ERIC HAUSER (US) | 2012-04-19 | — | — | WO | claimed |
| US-20090209654-A1 | Prenylflavonoid Formulations | BIOACTIVES, INC. | 2009-08-20 | — | — | US | claimed |
| WO-2008095189-A1 | METHODS AND COMPOSITIONS FOR TREATING DYSLIPIDAEMIA | BIOACTIVES, INC. (US) | 2008-08-07 | — | — | WO | claimed |
| EP-1909584-A2 | PRENYLFLAVONOID FORMULATIONS | Bioactives, Inc. (US) | 2008-04-16 | — | — | EP | claimed |
| US-20070218155-A1 | Methods and compositions for treating dyslipidaemia | BIOACTIVES, INC. | 2007-09-20 | — | — | US | claimed |
| WO-2007016578-A2 | PRENYLFLAVONOID FORMULATIONS | BIOACTIVES, INC. (US) | 2007-02-08 | — | — | WO | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20230059124-A1 | Novel TAS2R38 Bitter Taste Receptor Agonist | BIOACTIVES INC. | 2023-02-23 | — | — | US | disclosed |
| WO-2012051107-A2 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE-EFFECT | KUHRTS ERIC HAUSER (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2012003515-A2 | STABLE FATTY ACID-CONTAINING FORMULATIONS | KUHRTS ERIC HAUSER (US) | 2012-01-05 | — | — | WO | disclosed |
| US-20090209654-A1 | Prenylflavonoid Formulations | BIOACTIVES, INC. | 2009-08-20 | — | — | US | disclosed |
| WO-2008095189-A1 | METHODS AND COMPOSITIONS FOR TREATING DYSLIPIDAEMIA | BIOACTIVES, INC. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20070218155-A1 | Methods and compositions for treating dyslipidaemia | BIOACTIVES, INC. | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150209307-A1 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE | CUTA, PSEN2, PNN | PTPN1 3519/4885AKR1B10 2728/4885AKR1B1 2708/4885 |
| US-20190046469-A1 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE | CUTA, PSEN2, PNN | PTPN1 3519/4885AKR1B10 2728/4885AKR1B1 2708/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | PTPN1 1308/4885AKR1B10 2495/4885AKR1B1 2220/4885 |
| US-20230059124-A1 | Novel TAS2R38 Bitter Taste Receptor Agonist | TAS2R38, TAS2R8, TAS2R50 | PTPN1 1257/4885AKR1B10 2774/4885AKR1B1 3410/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | PTPN1 1520/4885AKR1B10 1741/4885AKR1B1 2215/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | PTPN1 1520/4885AKR1B10 1741/4885AKR1B1 2215/4885 |
| US-20140045904-A1 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE EFFECT | NAPRT, NISCH, NAMPT | PTPN1 2794/4885AKR1B10 845/4885AKR1B1 430/4885 |
| US-20090209654-A1 | Prenylflavonoid Formulations | TP53, CYP46A1, HPGD | PTPN1 4000/4885AKR1B10 402/4885AKR1B1 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.